Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Fellow THTX Shareholders

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Mar 07, 2023 1:07pm

110 Views

Post# 35324006

RE:Fellow THTX Shareholders

I sure hope Thera is getting some uncomfortable calls from concerned institutional holders today and they actually listen to them now.

Geeez is this really what it took for them to realize the current plan isn’t working and time rethink it?

Going with the completely unsubstantiated theory that our crackerjack finance negotiator Dubuc is the one at Thera who is guiding IR away from marketing to us lowly retail investors.

<< Previous

Bullboard Posts

Next >>

New Canadian cannabis regulations to streamline ailing industry